Sized to Perfection
Emultech at the 2023 Microsphere Summit
Please join Emultech at the 2023 Microsphere Summit in Liverpool, UK on 29th & 30th March!
The Microsphere Summit is designed to highlight best practice and advancements in technology in the field of Long Acting Release (LAR) injectable drug development and production. If features presentations from leading industry experts, knowledge exchange, practical workshops and case studies.
Advantages of microfluidic emulsification
- Monodisperse nano- and microparticles of all sizes and properties
- High drug loading through high encapsulation efficiencies
- Safe encapsulation of proteins due to gentle nature of the process
- Improved injectability through uniformity of particles
- Broad range of polymer solutions
- Minimal waste of expensive raw materials since no sieving is required
Partner with Emultech to improve your products
- Patented solutions add protection for your product
- Experts in controlled release drug delivery from days to weeks to months
- Injectable and other applications from dermal fillers to embolization to drug delivery
- The only continuous and scalable microfluidics system
- Full range of services in formulation, development and manufacturing
- Flexible partnerships from products and solutions provider to joint ventures
From feasibility to production
Supports discovery, to clinical, to commercial production
Applications
A wide range of particles can be produced with microfluidic emulsification with sizes ranging from nano to micro. Emultech’s technology platform supports oil-in-water and water-in-oil emulsification as well as hydrodynamic flow focussing.
| Unloaded | Loaded | |
|---|---|---|
| Microspheres |
Medical devices (Fillers, Embolization, Wound healing) |
Controlled release small molecules |
| Hydrospheres |
Controlled release biologics |
|
| Polymeric nanoparticles |
Targeted delivery small molecules |
Emultech’s Microfluidic Emulsification
On a unique small chip with up to 100 identical channels emulsion droplets are continuously produced in a fully controlled, predictable and scalable manner.
Mission
Our mission is to create highly differentiated products featuring our proprietary monodisperse microspheres.
Vision
We bring significant value to our global pharma and medical device partners through a cost efficient and risk minimized pathway, designing injectable and other products with superior performance and consistency.
The latest news and events
Read all about what’s happening at Emultech. The latest news, job openings and upcoming events.
Emultech at the Aesthetics conference
Emultech will be attending the upcoming ACE Aesthetics Conference to be held March 10th & 11th in London. If you’d like to meet with any of our team there, please send a request to info@renehansen.com or and we’ll make a date. We hope to see you there!
Emultech at the 2023 Microsphere Summit
Please join Emultech at the 2023 Microsphere Summit in Liverpool, UK on 29th & 30th March! The Microsphere Summit is designed to highlight best practice and advancements in technology in the field of Long Acting Release (LAR) injectable drug development and production. If features presentations from leading industry experts, knowledge exchange, practical workshops and case studies. Emultech will be […]
Osteo-Pharma and Emultech announce joint venture
Osteo-Pharma and Emultech announce joint venture to develop First-In-Class disease modifying treatment for Osteoarthritis AMSTERDAM, November 17, 2021 (Newswire.com) – Emultech and Osteo-Pharma today announced a joint venture to develop what could be the first disease-modifying treatment for osteoarthritis of the knee. The joint venture, to be called Bone-Tech, brings together Osteo-Pharma’s novel combination drug therapy for the local treatment of […]
Contact
Contact us now to arrange for a rapid evaluation of your formulation. Interested in meeting Emultech? Check out our Media page to see where you can find us next.